Literature DB >> 15921172

Comparison of adrenal function tests in children--the glucagon stimulation test allows the simultaneous assessment of adrenal function and growth hormone response in children.

Antje Böttner1, Jürgen Kratzsch, Sabine Liebermann, Alexandra Keller, Roland W Pfaffle, Wieland Kiess, Eberhard Keller.   

Abstract

The accurate assessment of adrenal function is necessary in many children with suspicion of pituitary insufficiency. The objective of this study was to evaluate the adrenal response during the glucagon stimulation test (GST) and its diagnostic utility in children. A total of 290 children, aged 10.1 +/- 5.0 years, were evaluated for adrenal function using the corticotrophin releasing hormone (CRH) test, the GST, and/or the insulin tolerance test (ITT). Glucagon stimulation provoked a substantial rise in cortisol and adrenocorticotropin (ACTH) that was independent of gender, age, or underlying growth hormone deficiency. There were no differences in peak cortisol levels in the GST compared to the CRH test in pair-wise intra-individual analyses in children with both tests performed within one year (615.4 +/- 30.5 vs 602.8 +/- 22.4 nmol/l, n=52). Similarly, there were no differences in the cortisol response between the ITT and CRH test. Peak cortisol levels in the CRH test correlated with the GST and the ITT. The magnitude of ACTH response, in contrast, was highest in the ITT with a 9.8-fold increase over baseline, while the increase in the GST (3.1-fold) and CRH test (1.6-fold) were more subtle. Since there is controversy concerning reliable cut-off values for adrenal function tests in children, we analyzed cut off levels in 186 children, including 26 children with adrenal insufficiency, using the CRH test. A peak cortisol level of 450 nmol/l provided the best balance of sensitivity (88.5%) and specificity (86.8%), while higher cut-off levels did not increase sensitivity but lost in specificity. In summary, the GST constitutes an1 equally sensitive test for the assessment of adrenal function in children that is not confounded by anthropometric parameters and is generally not accompanied by major side effects. It allows the simultaneous assessment of corticotroph and somatotroph function and may thus constitute a valuable alternative to the ITT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15921172     DOI: 10.1515/jpem.2005.18.5.433

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  10 in total

1.  Adrenal function: A gold standard test for adrenal insufficiency in children?

Authors:  Hedi L Claahsen-van der Grinten; Barto J Otten
Journal:  Nat Rev Endocrinol       Date:  2010-11       Impact factor: 43.330

Review 2.  Recovery of steroid induced adrenal insufficiency.

Authors:  Areej K Younes; Noor K Younes
Journal:  Transl Pediatr       Date:  2017-10

3.  Effects of leukemia inhibitory receptor gene mutations on human hypothalamo-pituitary-adrenal function.

Authors:  Tulay Guran; Omer Guran; Cem Paketci; Osman Kipoglu; Irfan Firat; Serap Turan; Zeynep Atay; Belma Haliloglu; Abdullah Bereket
Journal:  Pituitary       Date:  2015-08       Impact factor: 4.107

4.  Adding Glucagon-Stimulated GH Testing to the Diagnostic Fast Increases the Detection of GH-Sufficient Children.

Authors:  Colin P Hawkes; Adda Grimberg; Vivian E Dzata; Diva D De Leon
Journal:  Horm Res Paediatr       Date:  2016-03-17       Impact factor: 2.852

Review 5.  Is the fear from insulin tolerance test in the evaluation of short stature justified?

Authors:  Aaron Hanukoglu; Regina Weisglass
Journal:  Eur J Pediatr       Date:  2022-04-23       Impact factor: 3.183

6.  A significant proportion of thalassemia major patients have adrenal insufficiency detectable on provocative testing.

Authors:  Karen E Huang; Steven D Mittelman; Thomas D Coates; Mitchell E Geffner; John C Wood
Journal:  J Pediatr Hematol Oncol       Date:  2015-01       Impact factor: 1.289

Review 7.  Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.

Authors:  Niki Rensen; Reinoud Jbj Gemke; Elvira C van Dalen; Joost Rotteveel; Gertjan Jl Kaspers
Journal:  Cochrane Database Syst Rev       Date:  2017-11-06

8.  Copeptin as a marker of an altered CRH axis in pituitary disease.

Authors:  Krzysztof C Lewandowski; Andrzej Lewiński; Elżbieta Skowrońska-Jóźwiak; Katarzyna Malicka; Wojciech Horzelski; Georg Brabant
Journal:  Endocrine       Date:  2017-08-09       Impact factor: 3.633

9.  Evaluation of the hypothalamic-pituitary-adrenal axis and its relationship with central respiratory dysfunction in children with Prader-Willi syndrome.

Authors:  Veronique Beauloye; K Dhondt; W Buysse; A Nyakasane; F Zech; J De Schepper; S Van Aken; K De Waele; M Craen; I Gies; I Francois; D Beckers; A Desloovere; G Francois; M Cools
Journal:  Orphanet J Rare Dis       Date:  2015-09-02       Impact factor: 4.123

10.  Copeptin under glucagon stimulation.

Authors:  Krzysztof C Lewandowski; Andrzej Lewiński; Elżbieta Skowrońska-Jóźwiak; Magdalena Stasiak; Wojciech Horzelski; Georg Brabant
Journal:  Endocrine       Date:  2015-11-17       Impact factor: 3.633

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.